Latest news

Journal overview

Information for authors

Call for papers

The Editor in Chief welcomes submissions.  Submissions of the following types are invited:

- Original research articles.

- Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.

- Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.

- Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.

- Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.

- Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.

- Short reports: brief reports of data from original research.

- Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.

- Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.

All submissions are subject to prompt, objective and fair peer review.  Authors are continually informed of the progress of their paper and our staff are friendly and responsive.

Criteria for publication

Publication is dependent on peer reviewers' judgement of papers.  Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility.

Previous work in the field must be acknowledged and papers should read without unreasonable difficulty.  Papers should fit comfortably within the scope of the journal.

Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research.  They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible.

Articles submitted to other journals

We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication.

Editor in Chief profile

Dr Garry M. Walsh, Reader in Immunity and Inflammation and Principal Investigator, Asthmatic and Allergic Inflammation Group, School of Medicine, Institute of Medical Sciences, University of Aberdeen, Aberdeen, U.K.

Dr Walsh’s research career spans 25 years during which his work has focused on the elucidation of the molecular mechanisms controlling the initiation and resolution of the inflammatory processes underlying asthma, COPD and allergic disease with an emphasis on the role played by airway epithelial cells and eosinophils. Dr Walsh has published in both basic and clinical science, including several seminal papers on cell death, apoptotic cell disposal and the clinical relevance of apoptotic cell clearance.

He has secured over £2 million in research funding as principal investigator from Research Charities including the Wellcome Trust, the Medical Research Council and industry. Dr Walsh has published more than 55 peer reviewed articles and over 50 editorials, reviews and book chapters; these have been cited over 2000 times. He has been an invited speaker and/or chairman at more than 30 prestigious international meetings. Dr Walsh is founding Editor-in-Chief of Therapeutics & Clinical Risk Management and serves as editorial board member for seven international peer-reviewed journals.   He is a regular reviewer for over thirty other journals and is a member of many professional organizations and committees, including the Collegium Internationale Allergologicum.  Dr Walsh is Visiting Professor of Immunity and inflammation in the Department of Clinical Medicine at Trinity College, Dublin, Ireland

Editorial Board

Demosthenes Bouros, MD, PhD
Professor, Department of Pneumenology, Democrius University of Thrace, Alexandroupolis, Greece

David R P Guay, PharmD
Professor of Experimental and Clinical Pharmacology, Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA

Thomas Kresina, PhD
Senior Public Health Investigator, Division of Pharmacologic Therapies, Substance Abuse and Mental Health Services Administration, Rockville, MD, USA

Neil Campbell Thomson, MBChB, MD, FRCP
Professor of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, United Kingdom

Nizar Souaayh, MD
Assistant Professor, Neurology, New Jersey Medical School, Newark, NJ, USA
 

Editorial Board members are sought.  Visit this page to apply.